MDCT diagnosis of synchronous primary gastrointestinal tract carcinoma and other solid malignancies: case series study

Egyptian Journal of Radiology and Nuclear Medicine

Table 1 Characteristics of 34 patients with synchronous primary gastrointestinal tract carcinoma and other solid malignancies

Case no	Age/sex	Colonic carcinoma				Extra-colonic malignancy
Case no	Age/sex	TNM staging				Site	TNM staging
Colonic carcinoma
1	68/F	T4a	N1b	M0	IIIB	Renal	T1a	N0	M0	I
2	68/M	T4a	N1b	M0	IIIB	Renal	T1b	N0	M0	I
3	58/M	T4a	N2b	M0	IIIC	Renal	T1a	N0	M0	I
4	65/F	T3	N1a	M0	IIIB	Renal	T1a	N0	M0	I
5	67/M	T4a	N2a	M0	IIIC	Renal	T1b	N0	M0	I
6	54/F	T4a	N2b	M0	IIIB	Breast	T2	N0	M0	IIA
7	65/F	T4a	N2b	M1C	IVC	Breast	T2	N0	M0	IIA
8	60/F	T4b	N0	M0	IIC	Breast	Recurrent metastatic breast cancer
9	65/F	T4a	N0	M0	IIB	HCC	A (BCLC staging)
10	66/M	T3	N1	M0	IIIB	HCC	C (BCLC staging)
11	64/F	T4b	N1	M0	IIIC	HCC	C (BCLC staging)
12	76/M	T3	N2a	M0	IIIB	Prostate	T3a	N0	M0	IIIB
13	82/M	T3	N0	M0	IIA	Prostate	T2c	N0	M0	IIC
14	71/M	T4a	N0	M0	IIB	Prostate	T2c	N0	M0	IIC
15	52/M	T3	N2a	M0	IIIB	UB	T3b	N0	M0	IIIA
16	74/M	T3	N0	M0	IIA	UB	T3b	N0	M0	IIIA
17	52/F	T3	N2a	M1a	IVA	Ovarian	Local recurrent
18	65/F	T3	N2a	M1a	IVA	Ovarian	I (FIGO staging)
19	53/F	T4a	N0	M0	IIB	Endo	IB (FIGO staging)
20	66/F	T4a	N1	M0	IIIB	Endo	IIIC1 (FIGO staging)
21	69/M	T4a	N1	M1a	IVA	NHL	III (Ann Arbor Staging)
22	60/F	T2	N2a	M0	IIIB	HD	II (Ann Arbor Staging)
23	68/M	T4a	N2a	M0	IIIC	Thyroid	T3a	N1b	M0	II
24	66/F	T3	N0	M0	IIA	Lung	T1c	N2	M0	IIIA

	Age/sex	Periampullary				Extra-periampullary malignancy
		TNM staging				Site	TNM staging
		T	N	M	Stage		T	N	M	Stage
Carcinoma
31	65/F	T3b	N0	M0	IIB	UB	T2b	N0	M0	II
32	80/M	T3b	N0	M0	IIB	UB	T3b	N0	M0	IIIA
33	74/M	T1	N0	M0	IA	Renal	T1a	N0	M0	I
	Neuroendocrine
34	64/F	T2	N0	M0	II	Breast	T4b	N2a	M0	IIIA

BCLC: Barcelona Clinic Liver Cancer staging classification, Endo.: Endometrial carcinoma, FIGO: the International Federation of Gynecology and Obstetrics, HCC: hepatocellular carcinoma, HD: Hodgkin disease, NHL: Non-Hodgkin lymphoma, RCC: renal cell carcinoma, UB: urinary bladder